Abstract
CD24 is expressed on a broad range of cells in the immune and central nervous systems and appears to be required for development of experimental autoimmune encephalomyelitis in mice. Association of a CD24 Ala/Val coding polymorphism with susceptibility to and progression of multiple sclerosis was recently reported. We typed this coding polymorphism in a combined cohort of 1,180 cases and 1,168 unrelated and family-based controls from Belgium and the UK, but were unable to confirm either association. Since the CD24 gene is part of a segmental duplication, special care is required for the identification and genotyping of single nucleotide polymorphisms.
Publication types
-
Clinical Trial, Phase II
-
Comparative Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alanine / genetics*
-
CD24 Antigen / genetics*
-
Chemotaxis, Leukocyte / drug effects
-
Chemotaxis, Leukocyte / immunology
-
Double-Blind Method
-
Female
-
Humans
-
Longitudinal Studies
-
Male
-
Middle Aged
-
Mitoxantrone / therapeutic use
-
Multiple Sclerosis, Chronic Progressive / drug therapy
-
Multiple Sclerosis, Chronic Progressive / genetics*
-
Multiple Sclerosis, Chronic Progressive / pathology
-
Polymorphism, Single Nucleotide*
-
Receptors, Chemokine / biosynthesis
-
Valine / genetics*
Substances
-
CD24 Antigen
-
Receptors, Chemokine
-
Mitoxantrone
-
Valine
-
Alanine